Bill > H0266

This bill introduces comprehensive regulations for the 340B prescription drug pricing program in Vermont, focusing on protecting 340B covered entities and contract pharmacies from manufacturer discrimination. The bill defines key terms related to the 340B program, such as 340B covered entities, contract pharmacies, and drugs, and prohibits manufacturers from interfering with drug acquisition, delivery, or dispensing. It mandates that manufacturers offer 340B drug pricing as upfront discounts rather than rebates and allows entities harmed by violations to seek legal action. Additionally, the bill requires hospitals participating in the 340B program to submit annual detailed reports to the Green Mountain Care Board, including information about drug acquisition costs, payment amounts, and how the program's revenue benefits community services. The legislation also introduces a price cap for outpatient prescription drugs, limiting hospital charges to 120 percent of the average sales price, with the goal of reducing healthcare costs. The reporting requirements will be in effect until January 1, 2031, and the pricing limitations will take effect on January 1, 2026, with specific provisions to protect rural healthcare services and critical access hospitals.

Health and Social Services

https://legislature.vermont.gov/bill/status/2026/H.266